|
23/07/2021 |
SOBERANA CENTRO |
FINLAY |
Registered |
|
23/07/2021 |
SOBERANA PEDIATRIA CLINICA 1 |
FINLAY |
Registered |
|
15/07/2021 |
Rectal ozone therapy in high-risk symptomatic SARS-CoV-2 positive patients |
CPN |
Registered |
|
09/07/2021 |
CIGB-Mambisa/Abdala in convalescents |
CIGB |
Registered |
|
01/07/2021 |
Evaluation of the safety and immunogenicity of the vaccine candidate "ABDALA" in children and adolescents |
CIGB |
Registered |
|
30/06/2021 |
Itolizumab-Plasmapheresis in patients with COVID-19 |
CIM |
Registered |
|
30/06/2021 |
Anti SARS-CoV-2 gammaglobulin |
AICA |
Registered |
|
30/06/2021 |
Policosanol + aspirin in post-stroke cognitive impairment |
CPN |
Registered |
|
30/06/2021 |
Policosanol in patients with pre-hypertension or with grade I hypertension |
CPN |
Registered |
|
18/06/2021 |
ior®EPOCIM in post-COVID-19 convalescent patients with cardiovascular, renal and/or respiratory disorders |
CIM |
Registered |
|
18/06/2021 |
CIMAvax-EGF®-post-COVID19 convalescent with respiratory disorders-adults-Phase II (CORVAXCIM) |
CIM |
Registered |
|
10/06/2021 |
SOBERANA PEDIATRIA |
FINLAY |
Registered |
|
27/05/2021 |
D004 (Palmex) vs Saw palmetto, Finasteride and Tamsulosin in patients with BPH |
CPN |
Registered |
|
22/05/2021 |
Abexol (suspension) versus Abexol (tablets) in patients with gastrointestinal symptoms |
CPN |
Registered |
|
22/05/2021 |
Safety and efficacy of CIMAvax®-EGF in combination with tyrosine kinase inhibitors in patients with advanced stage Non-Small Cell Lung Cancer and EGFR mutations |
CIM |
Registered |
|
21/05/2021 |
Preventive use of CIMAvax-EGF in patients at high risk of lung cancer. PREVAX |
CIM |
Registered |
|
21/05/2021 |
Nimotuzumab in COVID-19 |
CIM |
Registered |
|
12/05/2021 |
CIMAvax-EGF in different maintenance schemes |
CIM |
Registered |
|
11/05/2021 |
Doxycycline for prostate cancer |
SSA |
Registered |
|
09/04/2021 |
SOBERANA PLUS |
FINLAY |
Registered |
